Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
EIR
•Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services•December 7, 2018

Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services – FDA EIR, Dec 7, 2018

Record Details

An FDA inspection of Lyophilization Services of New England, Inc. (LSNE), a contract manufacturer of sterile drug products, was conducted from November 20 to December 7, 2018. This comprehensive inspection, performed under Compliance Program 7356.002A for Sterile Drug Process Inspections, evaluated the company's Quality, Facilities and Equipment, Production, and Laboratory Control Systems across its Bedford, NH facilities. At the inspection's conclusion, LSNE received a four-item FDA Form 483, detailing significant observations. Key issues included the Quality Unit's failure to routinely evaluate and approve quality processes such as deviation investigations, CAPAs, and qualification activities within established timelines. The firm's water system design and its sanitization program were deemed inadequate. Furthermore, LSNE had not thoroughly investigated patient complaints concerning difficulties in opening drug product vials. Finally, the in-process sampling procedure for drug products in the formulation tank was found to be deficient, with an operator observed using improper aseptic technique. LSNE management acknowledged the observations and committed to submitting a written response to the agency within 15 business days, outlining corrective actions for these regulatory deficiencies.

Company
Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
Inspection date
December 7, 2018
Product type
drugs
Office
New England District Office
People
  • Jay Bonewit (company_representative)
  • Sean R. Marcsisin (Senior Consumer Safety Officer - Pharmaceutical Quality)
  • Thomas McGrath (recipient)
  • Robert J. Martin
  • Shawn Cain (recipient)
View Company Profile

ID · 35bdd5a0-2438-4108-85fb-91d7aa287280

Violation Codes6
21 CFR 211.113(b)21.U.S.C. 355(a)21 CFR 21121 CFR 211.19221 CFR 211.6321 CFR 211.22(d)

Full citation text and observation details available on the Dashboard.

Other documents for Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
  • 483 - 2026-06-10June 10, 2026
  • 483 - 2023-09-27September 27, 2023
  • 483 - 2021-04-15April 15, 2021
  • 483 - 2020-11-05November 5, 2020
  • 483 - 2018-12-07December 7, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.